To compare Selective Laser Trabeculoplasty (SLT) with Latanoprost eye drops as first line therapy in Primary Open Angle Glaucome (POAG) patients residing in Africa.

Linda Visser


Patients residing in Africa with established or newly diagnosed primary open angle glaucoma or patients with POAG currently on single drug therapy (excluding prostaglandin analogues) and elevated IOP are recruited in St. Aidan’s Mission Hospital. If clinically indicated both eyes will be treated however one eye per patient will be included in the study. Following diagnosis and informed consent to study participation patients will be randomized to receive either 360 degree SLT or latanoprost (prostaglandin analogue) eye drops with instructions for use and prescription to obtain ongoing supplies of the drug. Intraocular pressure will be measured at regular intervals of 3, 6 and 12 months. The primary outcome measure of the study is intraocular pressure at 12 months. Secondary outcomes are visual acuity, additional intervention rate, compliance and complications.